발행물
컨퍼런스
EBMT 48th annual meeting
2022
,
Allogeneic stem cell transplantation with 3-days busulfan plus fludarabine as conditioning regimen for patients with relapsed and refractory T- and NK/T-cell lymphomas
Update on MM 2022
Treatment of newly diagnosed myeloma transplant eligible: induction and transplantation
18th International myeloma workshop
2021
Pomalidomide-based chemotherapy in plasmacytoma at relapse
Real-world toxicity and efficacy of ixazomib, lenalidomide and dexamethasone in Asian RRMM patients supported by the patient assistance program
International congress of blood and marrow transplantation 2021
HSCT in patients with blastic plasmacytic dendritic cell neoplasm